Cargando…

Influence of Government Price Regulation on the Price, Volume and Spending of Antibiotics in China: A Controlled Interrupted Time Series Study

Background: Chinese government established maximum retail prices for antibiotics listed in China’s National Reimbursement List in February 2013. This study aimed to analyze the impact of pharmaceutical price regulation on the price, volume and spending of antibiotics in China. Methods: An interrupte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wushouer, Haishaerjiang, Luo, Zhenhuan, Guan, Xiaodong, Shi, Luwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kerman University of Medical Sciences 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278607/ https://www.ncbi.nlm.nih.gov/pubmed/32702801 http://dx.doi.org/10.34172/ijhpm.2020.113

Ejemplares similares

The impacts of government reimbursement negotiation on targeted anticancer medication price, volume and spending in China
por: Zhang, Yichen, et al.
Publicado: (2021)

Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study
por: Guan, Xiaodong, et al.
Publicado: (2019)

Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
por: Huang, Cong, et al.
Publicado: (2022)

Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis
por: Huang, Cong, et al.
Publicado: (2021)

Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017
por: Bai, Lin, et al.
Publicado: (2020)

Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
por: Zhang, Yichen, et al.
Publicado: (2022)

The Impact of Sanming Healthcare Reform on Antibiotic Appropriate Use in County Hospitals in China
por: Hu, Lin, et al.
Publicado: (2022)

Secular trend analysis of antibiotic utilisation in China’s hospitals 2011–2018, a retrospective analysis of procurement data
por: Wushouer, Haishaerjiang, et al.
Publicado: (2020)

Outpatient Antibiotic Prescribing Patterns and Appropriateness for Children in Primary Healthcare Settings in Beijing City, China, 2017–2019
por: Wushouer, Haishaerjiang, et al.
Publicado: (2021)

The impact of physicians’ knowledge on outpatient antibiotic use: Evidence from China's county hospitals
por: Wushouer, Haishaerjiang, et al.
Publicado: (2020)

Medical insurance and healthcare utilization among the middle-aged and elderly in China: evidence from the China health and retirement longitudinal study 2011, 2013 and 2015
por: Zhou, Yue, et al.
Publicado: (2020)

Antibiotic use and irrational antibiotic prescriptions in 66 primary healthcare institutions in Beijing City, China, 2015–2018
por: Taxifulati, Yumiti, et al.
Publicado: (2021)

The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis
por: Rong, Xuejing, et al.
Publicado: (2020)

Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending
por: WOUTERS, OLIVIER J., et al.
Publicado: (2017)

Differences in reimbursement listing of anticancer therapies in China: an observational study
por: Guan, Xiaodong, et al.
Publicado: (2020)

Outpatient prescribing pattern for acute bronchitis in primary healthcare settings in China
por: Fu, Mengyuan, et al.
Publicado: (2021)

Impact of the Low-Price Medicine Policy on Medicine Supply in China: An Interrupted Time-Series Analysis
por: Zhao, Mingyue, et al.
Publicado: (2021)

Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending
por: Huang, Tao, et al.
Publicado: (2021)

Impacts of National Drug Price Negotiation on Expenditure, Volume, and Availability of Targeted Anti-Cancer Drugs in China: An Interrupted Time Series Analysis
por: Sun, Yan, et al.
Publicado: (2022)

Protocol of a tailored educational intervention for general practitioners on potentially inappropriate medications among older patients at community healthcare institutions in Beijing, China: a cluster-randomised controlled trial
por: Fu, Mengyuan, et al.
Publicado: (2021)

Trends of Fixed-Dose Combination Antibiotic Consumption in Hospitals in China: Analysis of Data from the Center for Antibacterial Surveillance, 2013–2019
por: Wushouer, Haishaerjiang, et al.
Publicado: (2022)

Understanding Differences in Health Care Spending: A Comparative Study of Prices and Volumes Across OECD Countries
por: Lorenzoni, Luca, et al.
Publicado: (2022)

Clinical Outcome and Medical Cost of Originator and Generic Antihypertensive Drugs: A Population-Based Study in Yinzhou, China
por: Huang, Tao, et al.
Publicado: (2022)

Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs
por: Docteur, Elizabeth, et al.
Publicado: (2015)

Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis
por: Wang, Ni, et al.
Publicado: (2021)

China and Weapons of Mass Production: The "China Price" Is the "Cheating Price
por: Navarro, Peter
Publicado: (2010)

Evaluation of prescription review and feedback policy on rational antibiotic use in primary healthcare settings in Beijing, China: a qualitative study using the Theoretical Domains Framework and the behaviour change wheel
por: Wushouer, Haishaerjiang, et al.
Publicado: (2023)

Asset pricing implications of good governance
por: Lehnert, Thorsten
Publicado: (2019)

Erratum to Understanding Differences in Health Care Spending: A Comparative Study of Prices and Volumes Across OECD Countries
Publicado: (2022)

Interrupted time-series analysis of the impact of generic market entry of antineoplastic products in China
por: Guan, Xiaodong, et al.
Publicado: (2018)

Price wars and price collusion in China's airline markets
por: Zhang, Yahua, et al.
Publicado: (2011)

Criteria for Drug Pricing: Preliminary Experiences with Modeling the Price-Volume Relationship
por: Messori, Andrea
Publicado: (2016)

Impact of China’s healthcare price reforms on traditional Chinese medicine public hospitals in Beijing: an interrupted time-series study
por: Zhu, Dawei, et al.
Publicado: (2019)

Changing Characteristics of Pharmaceutical Prices in China Under Centralized Procurement Policy: A Multi-Intervention Interrupted Time Series
por: Long, Hongfei, et al.
Publicado: (2022)

Acid Suppression Use Among Infants in One Tertiary Children's Hospital in China, 2015–2018: A Retrospective Observational Study
por: Zhou, Yue, et al.
Publicado: (2021)

Impacts of adjustment of National Reimbursement Drug List on orphan drugs volume and spending in China: an interrupted time series analysis
por: Yi, Hongbin, et al.
Publicado: (2023)

Impact of house price growth on mental health: Evidence from China
por: Wei, Guoxu, et al.
Publicado: (2020)

Inpatient antibacterial use trends and patterns, China, 2013–2021
por: Wushouer, Haishaerjiang, et al.
Publicado: (2023)

Effects of Volume-Price Contracts on Pharmaceutical Prices: A Retrospective Comparative Study of Public Hospitals in Hubei of China
por: Li, Zhuoxian, et al.
Publicado: (2021)

Trends and patterns of antibiotic consumption in China’s tertiary hospitals: Based on a 5 year surveillance with sales records, 2011-2015
por: Wushouer, Haishaerjiang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vu7c6cbj9v8994sk93q54hh4mv